Infliximab treatment influences the serological expression of matrix metalloproteinase (MMP)-2 and -9 in Crohn's disease. (Record no. 16806455)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01899 a2200529 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250515053859.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 200708s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1078-0998 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1002/ibd.20100 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Gao, Qiang |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20070822 |
245 00 - TITLE STATEMENT | |
Title | Infliximab treatment influences the serological expression of matrix metalloproteinase (MMP)-2 and -9 in Crohn's disease. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Inflammatory bowel diseases |
Date of publication, distribution, etc. | Jun 2007 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 693-702 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adolescent |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adult |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Anti-Inflammatory Agents |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antibodies, Monoclonal |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Biomarkers |
General subdivision | blood |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Crohn Disease |
General subdivision | blood |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Enzyme-Linked Immunosorbent Assay |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Follow-Up Studies |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Gene Expression |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Immunohistochemistry |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Infliximab |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Matrix Metalloproteinase 2 |
General subdivision | blood |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Matrix Metalloproteinase 9 |
General subdivision | blood |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Middle Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Neutrophils |
General subdivision | enzymology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | RNA, Messenger |
General subdivision | genetics |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Reverse Transcriptase Polymerase Chain Reaction |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Treatment Outcome |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Meijer, Martin J W |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Schlüter, Ulrike G |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | van Hogezand, Ruud A |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | van der Zon, Johanna M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | van den Berg, Marlies |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | van Duijn, Wim |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Lamers, Cornelis B H W |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Verspaget, Hein W |
773 0# - HOST ITEM ENTRY | |
Title | Inflammatory bowel diseases |
Related parts | vol. 13 |
-- | no. 6 |
-- | p. 693-702 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1002/ibd.20100">https://doi.org/10.1002/ibd.20100</a> |
Public note | Available from publisher's website |
No items available.